Stockreport

PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights

PepGen Inc.  (PEPG) 
PDF – FREEDOM-DM1 data from 5 and 10 mg/kg cohorts in patients with DM1 expected in the first quarter of 2025 –– Study designs of CONNECT program optimized based on encourag [Read more]